ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,91
-1,31%
Dow Jones
41 618,99
-0,70%
DAX
22 328,77
-1,23%
Brent Oil
69,585
0,79%
Bitcoin
83 288,48
6,14%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Vistagen Therapeutics Inc (VTGN) Cours

Vistagen Therapeutics Inc

Vistagen Therapeutics Inc (VTGN)

NASDAQ
2,72
0,065
( 2,45% )
Mis à jour : 20:16:31
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
2,72
Prix Achat
2,71
Prix Vente
2,73
Volume échangé
61 816
2,59 Fourchette du Jour 2,75
2,22 Plage de 52 semaines 5,74
Cap du marché
78,505M
Clôture Veille
2,655
Ouverture
2,63
Dernière Transaction
18
@
2.725
Dernière heure de transaction
20:14:43
Volume financier
US$ 162 968
VWAP
2,6363
Volume moyen (3 m)
257 074
Actions en circulation
28 862 085
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,66
Bénéfice par action (BPA)
-1,02
Chiffre d'affairess
1,06M
Bénéfice net
-29,36M

À propos de Vistagen Therapeutics Inc

Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen's pipeline includes six product candidates, including five ... Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen's pipeline includes six product candidates, including five clinical-stage investigational agents belonging to a new class of drugs known as pherines. Its portfolio includes PH94B, a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia. PH10, an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.vistagen.com
Siège social
Carson City, Nevada, USA
Fondé
-
Vistagen Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker VTGN. Le dernier cours de clôture d'Vistagen Therapeutics était de US$2,66. Au cours de la dernière année, les actions de Vistagen Therapeutics ont été négociées dans une fourchette de prix de US$ 2,22 à US$ 5,74.

Vistagen Therapeutics compte actuellement 28 862 085 actions en circulation. La capitalisation boursière d'Vistagen Therapeutics est de US$76,63 million. Vistagen Therapeutics a un ratio cours/bénéfice (ratio PE) de -2.66.

VTGN Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report
Edgar (US Regulatory)
06 Mars 2025
VTGN (2,45%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 Février 2025
VTGN (2,45%)

Form 8-K - Current report
Edgar (US Regulatory)
13 Février 2025
VTGN (2,45%)

Form 8-K - Current report
Edgar (US Regulatory)
05 Février 2025
VTGN (2,45%)

Form 8-K - Current report
Edgar (US Regulatory)
14 Janvier 2025
VTGN (2,45%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.26810.92985318112.4522.832.351586822.68488721CS
4-0.05-1.805054151622.773.12.351644842.75693014CS
120.2811.47540983612.443.3952.222570742.78768166CS
26-0.46-14.4654088053.183.3952.222257772.84028814CS
52-1.47-35.08353221964.195.742.221890493.43723322CS
156-34.78-92.746666666737.553.71.6229616306.87499698CS
260-14.38-84.093567251517.1106.51.62249778021.55724392CS

VTGN - Frequently Asked Questions (FAQ)

What is the current Vistagen Therapeutics share price?
The current share price of Vistagen Therapeutics is US$ 2,72
How many Vistagen Therapeutics shares are in issue?
Vistagen Therapeutics has 28 862 085 shares in issue
What is the market cap of Vistagen Therapeutics?
The market capitalisation of Vistagen Therapeutics is USD 76,63M
What is the 1 year trading range for Vistagen Therapeutics share price?
Vistagen Therapeutics has traded in the range of US$ 2,22 to US$ 5,74 during the past year
What is the PE ratio of Vistagen Therapeutics?
The price to earnings ratio of Vistagen Therapeutics is -2,66
What is the cash to sales ratio of Vistagen Therapeutics?
The cash to sales ratio of Vistagen Therapeutics is 73,44
What is the reporting currency for Vistagen Therapeutics?
Vistagen Therapeutics reports financial results in USD
What is the latest annual turnover for Vistagen Therapeutics?
The latest annual turnover of Vistagen Therapeutics is USD 1,06M
What is the latest annual profit for Vistagen Therapeutics?
The latest annual profit of Vistagen Therapeutics is USD -29,36M
What is the registered address of Vistagen Therapeutics?
The registered address for Vistagen Therapeutics is 701 S CARSON ST, STE 200, CARSON CITY, NEVADA, 89701
What is the Vistagen Therapeutics website address?
The website address for Vistagen Therapeutics is www.vistagen.com
Which industry sector does Vistagen Therapeutics operate in?
Vistagen Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RAYRaytech Holding Ltd
US$ 1,745
(100,57%)
96,73M
TSVT2seventy bio Inc
US$ 4,95
(76,79%)
29,45M
SYRSSyros Pharmaceuticals Inc
US$ 0,1449
(58,19%)
667,8M
SPHLSpringview Holdings Ltd
US$ 6,145
(50,61%)
1,25M
TNONTenon Medical Inc
US$ 1,8707
(49,66%)
36,3M
WCTWellchange Holdings Company Limited
US$ 0,765
(-69,52%)
33,95M
ARVNArvinas Inc
US$ 8,70
(-50,46%)
15,33M
LZMHLZ Technology Holdings Ltd
US$ 8,46
(-45,98%)
630,85k
SPGCSacks Parente Golf Inc
US$ 0,1039
(-35,10%)
30,95M
HTCOHigh Trend International Group
US$ 1,52
(-28,64%)
142,93k
SYRSSyros Pharmaceuticals Inc
US$ 0,1448
(58,08%)
674,69M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0387
(15,52%)
396,72M
NVDANVIDIA Corporation
US$ 110,82
(3,59%)
291,25M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8,1338
(10,21%)
279,34M
CUTRCutera Inc
US$ 0,1037
(-19,30%)
212,03M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
VTGN
Vistagen Therapeutics
USOTC
GLFH
Galenfeha (PK)
TG
213
Vow ASA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces